Strategic acquisitions Capitalize on Aatru Medical's acquisition of Exothermix to position sales pitches around enhanced NPWT technology, broadened component sourcing, and potential cross-sell opportunities for hospitals seeking integrated wound care solutions.

Regional expansion Leverage recent Latin America and US commercial launches to target regional distributors and healthcare systems with NPWT for closed incisions, emphasizing cost efficiency and portability to fit diverse surgical settings.

Regulatory readiness Highlight the 510(k) clearance as a proof point for safety and market readiness, facilitating conversations with large medical device customers who require compliant, ready-to-sell NPWT options.

Small team agility Position as a nimble partner capable of rapid pilots and quick support, appealing to hospitals and clinics seeking fast deployment of innovative, ultraportable incision NPWT solutions.

Funding and growth signals Use the company’s modest funding and revenue range to target budget-conscious procurement managers, presenting a scalable path from pilot programs to broader adoption as revenue grows.